Textbook Chapters

• I.B. Chapter in the Textbook of Pediatric Infectious Disease, sixth edition, 2009
• Botulism as an Intestinal Toxemia chapter in Infections of the Gastrointestinal Tract, 1995

Journal Articles

• Human Botulism Immune Globulin for the Treatment of Infant Botulism
• Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure
• Creation and Development of the Public Service Orphan Drug Human Botulism Immune Globulin
• More Clinical Mimics of Infant Botulism
• Early Severe Infantile Botulism
• Catastrophic Presentation of Infant Botulism May Obscure or Delay Diagnosis
• Infant Botulism Acquired from Household Dust Presenting as Sudden Infant Death Syndrome
• A case of infant botulism due to neurotoxigenic Clostridium butyricum Type E Associated with Clostridium difficile Colitis
• Clostridium difficile colitis associated with Infant Botulism
• Global Occurrence of Infant Botulism, 1976-2006
• First Case of Infant Botulism Caused by Clostridium baratii Type F in California
• Type F Infant Botulism: Investigation of Recent Clusters and Overview of This Exceedingly Rare Disease
• Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins
• Antimicrobial Susceptibility of 260 Clostridium botulinum Type A, B, Ba, and Bf Strains and a Neurotoxigenic Clostridium baratii Type F Strain Isolated from California Infant Botulism Patients
• Molecular Epidemiology of Infant Botulism in California and Elsewhere, 1976–2010
• Clinical Reasoning: An unexpected diagnosis in a 4-month-old infant with lethargy and H1N1 influenza

Requests for copies of recent publications can be made at ibtpp@infantbotulism.org

• Descriptive epidemiology of infant botulism in California: the first 40 years. Panditrao MV, Dabritz HA, Kazerouni N, Meissinger JK, Arnon SS. 2020.. J Pediatr 227: 247-257.
• Seven-year case-control study in California of risk factors for infant botulism. Panditrao MV, Dabritz HA, Kazerouni N, Damus K, Meissinger JK, Arnon SS. 2020. J Pediatr 227:258-267.
• Dual-toxin ("bivalent") infant botulism in California, 1976-2020: epidemiological, clinical and laboratory aspects. Pandiatrao MV, Chung CH, Khouri JM, Barash JR, Motter RN, Dover N, Arnon SS. Dual-toxin ("bivalent") infant botulism in California, 1976-2020: epidemiological, clinical and laboratory aspects. J Pediatr S0022-3476:00725-00729.
• Molecular characterization of a novel botulinum neurotoxin type H gene. Dover N, Barash JR, Hill KK, Xie G, Arnon SS. 2014. J Infect Dis 209(2):192-202.
• Closed genome sequence of Clostridium botulinum strain IBCA10-7060 type Bh. Dover N, Barash JR, Bell JM, Sylvester MD, Arnon SS. 2021. Microb Resour Announc 10(34):30038321.
• Duration of fecal excretion of Clostridium Botulinum and Botulinum Neurotoxin in Patients Recovering from infant Botulism. Dabritz HA, Payne JR, Khouri JM. J. 2023 Pediatr: Online ahead of print: 113396

Official State of California Department of Public Health website

• For more information about infant botulism, BabyBIG^® and our Program, you may also visit our webpage on the official State of California, Department of Public Health website:
  https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/InfantBotulism.aspx